New oral psoriasis treatment Icotyde shows superior results over injectables, delivering clear skin with a safe, once-daily ...

"I was very ashamed. I felt like everywhere people were judging me," Amber Dean tells PEOPLE, recalling when her symptoms ...

J&J’s Icotyde will take on AbbVie’s blockbuster injectable Skyrizi as analysts forecast a blockbuster future for the pill.

The company said the FDA approved Icotyde to treat moderate to severe plaque psoriasis in adults and pediatric patients 12 ...

Johnson & Johnson (JNJ) stock is in focus as US approves its once-daily pill Icotyde developed with Protagonist Therapeutics ...

"Walking around with this very visible, very robust ailment has a pretty tremendous impact on your mental health," Maddox ...

Johnson & Johnson and Protagonist Therapeutics are countering the swarm of injectable biologics that have long dominated the ...

Even as the prevalence of psoriasis increases around the world, with the highest proportions found in white populations, there is apparently a greater burden of disease among populations with skin of ...

In his late teens, two significant things happened in Brandon Catapane’s life. He shared with his family that he was gay. And at the same time, the areas of dry skin on his scalp that had caused ...

The clearance is the first for an oral peptide that blocks IL-23, the target of popular medicines like Skyrizi and Tremfya. J ...